Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Anika Therapeutics (ANIK)

Anika Therapeutics (ANIK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 137,865
  • Shares Outstanding, K 14,421
  • Annual Sales, $ 119,910 K
  • Annual Income, $ -56,390 K
  • EBIT $ 13 M
  • EBITDA $ 21 M
  • 60-Month Beta 0.51
  • Price/Sales 1.14
  • Price/Cash Flow 99.49
  • Price/Book 0.93

Options Overview Details

View History
  • Implied Volatility 335.50% (+7.64%)
  • Historical Volatility 29.23%
  • IV Percentile 98%
  • IV Rank 95.45%
  • IV High 350.20% on 12/08/25
  • IV Low 27.25% on 09/09/25
  • Expected Move (DTE 5) 1.79 (18.76%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 6
  • Volume Avg (30-Day) 101
  • Put/Call OI Ratio 0.17
  • Today's Open Interest 614
  • Open Int (30-Day) 4,395
  • Expected Range 7.77 to 11.35

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.19
  • Number of Estimates 1
  • High Estimate -0.19
  • Low Estimate -0.19
  • Prior Year -0.14
  • Growth Rate Est. (year over year) -35.71%

Price Performance

See More
Period Period Low Period High Performance
1-Month
9.22 +3.69%
on 11/21/25
10.30 -7.14%
on 11/13/25
-0.54 (-5.35%)
since 11/12/25
3-Month
8.56 +11.71%
on 09/16/25
10.75 -11.07%
on 11/05/25
+0.89 (+10.27%)
since 09/12/25
52-Week
7.87 +21.47%
on 07/31/25
18.37 -47.96%
on 02/05/25
-7.77 (-44.84%)
since 12/12/24

Most Recent Stories

More News
Anika: Q3 Earnings Snapshot

Anika: Q3 Earnings Snapshot

ANIK : 9.56 (+0.74%)
Anika Reports Third Quarter 2025 Financial Results

Commercial Channel revenue up 22% with continued strong Integrity ™ Implant System and Hyalofast ® growth, and double-digit International OA Pain Management growth Third and final Hyalofast...

ANIK : 9.56 (+0.74%)
Anika Therapeutics Reports Filing of Final PMA Module for Hyalofast® Cartilage Repair Scaffold and Data from U.S. Pivotal FastTRACK Phase III Study

BEDFORD, Mass., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global leader in joint preservation and regenerative solutions, announced that it filed the third and final...

ANIK : 9.56 (+0.74%)
Anika to Issue Third Quarter 2025 Financial Results on Wednesday, November 5, 2025

BEDFORD, Mass., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, announced today that it will issue...

ANIK : 9.56 (+0.74%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc. - ANIK

NEW YORK , Sept. 13, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Anika Therapeutics, Inc. ("Anika" or the "Company") (NASDAQ: ANIK). Such investors...

ANIK : 9.56 (+0.74%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc. - ANIK

NEW YORK , Sept. 8, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Anika Therapeutics, Inc. ("Anika" or the "Company") (NASDAQ: ANIK). Such investors...

ANIK : 9.56 (+0.74%)
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BEDFORD, Mass., Sept. 05, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global leader in the osteoarthritis pain management and regenerative solutions spaces focused on early...

ANIK : 9.56 (+0.74%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc. - ANIK

NEW YORK , Sept. 3, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Anika Therapeutics, Inc. ("Anika" or the "Company") (NASDAQ: ANIK). Such investors...

ANIK : 9.56 (+0.74%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc. - ANIK

NEW YORK , Aug. 22, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Anika Therapeutics, Inc. ("Anika" or the "Company") (NASDAQ: ANIK). Such investors...

ANIK : 9.56 (+0.74%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc. - ANIK

NEW YORK , Aug. 16, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Anika Therapeutics, Inc. ("Anika" or the "Company") (NASDAQ: ANIK). Such investors...

ANIK : 9.56 (+0.74%)

Business Summary

Anika Therapeutics, Inc. is a global, integrated orthopedic medicines company based in Bedford, Massachusetts. Anika is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies along the continuum of care, from palliative...

See More

Key Turning Points

3rd Resistance Point 9.82
2nd Resistance Point 9.73
1st Resistance Point 9.65
Last Price 9.56
1st Support Level 9.48
2nd Support Level 9.39
3rd Support Level 9.31

See More

52-Week High 18.37
Fibonacci 61.8% 14.36
Fibonacci 50% 13.12
Fibonacci 38.2% 11.88
Last Price 9.56
52-Week Low 7.87

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar